Search
for
Sort by
Research 301–330 of 1000+
- The childbearing years: hair diseases
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Graft-versus-host disease
- Hair Loss in Systemic Disease
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- Adult Group B Streptococcal Disease
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels
- Advances in Hair Diseases
- Immunosuppressive therapy in autoimmune disease — A review
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World
- Telogen effl uvium as the fi rst symptom of Crohn's disease in a child
- Multisystemic eosinophilic epitheliotropic disease in a horse
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Cutaneous signals of immune system disease
- Microneedle-Based Approaches for Skin Disease Treatment
- Racial and Gender Influences on Skin Disease
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Symptom management in inflammatory bowel disease
- The clinical spectrum of parathyroid disease
- Clinical description of a rare dermatological disease, acne Keloidalis Nuchae, and successful homoeopathic management: A case report
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- The Role of Histone Demethylases in Disease
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Hair Dye as a Potential Trigger for Relapse of Anti-GBM Disease: A Case Report
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology